Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 2 28-2, 2003, Pages

  Smith, Susan J ^a   Brookes Fazakerley, Steven ^a   Donnelly, Louise E ^a   Barnes, Peter J ^a   Barnette, Mary S ^b   Giembycz, Mark A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Inflammation; Lung

Indexed keywords

ANTIINFLAMMATORY AGENT; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE 7A; PHOSPHODIESTERASE 7A1; PHOSPHODIESTERASE 7A2; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLAMMATION; LUNG FIBROBLAST; MONOCYTE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0037308172     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00170.2002     Document Type: Article

References (44)

1. Barnes MJ, Cooper N, Davenport RJ, Dyke HJ, Galleway FP, Galvin FC, L Gowers L, Haughan AF, Lowe C, Meissner JW, Montana JG, Morgan T, Picken CL, and Watson RJ. Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors. Bioorg Med Chem Lett 11: 1081-1083, 2001.
2. Baumann MA and Paul CC. The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells 16: 16-24, 1998.
3. Birks EJ, Yacoub MH, Burton PS, Owen V, Pomerance A, O'Halloran A, Banner NR, Khaghani A, and Latif N. Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts. Transplantation 70: 1498-1506, 2000.
4. Bloom TJ and Beavo JA. Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc Natl Acad Sci USA 93: 14188-14192, 1996.
5. Castro A, Abasolo MI, Gil C, Segarra V, and Martinez A. CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-alpha] thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors. Eur J Med Chem 36: 333-338, 2001.
6. Compton CH, Gubb J, Nieman R, Edelson J, Amit O, Bakst A, Ayres JG, Creemers JP, Schultze-Werninghaus G, Brambilla C, and Barnes NC. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 358: 265-270, 2001.
7. Conti M and Jin SL. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol 63: 1-38, 1999.
8. Duplantier AJ, Biggers MS, Chambers RJ, Cheng JB, Cooper K, Damon DB, Eggler JF, Kraus KG, Marfat A, Masamune H, Pillar JS, Shirley JT, Umland JP, and Watson JW. Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret. J Med Chem 39: 120-125, 1996.
9. Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA, and Phillips SC. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97: 3702-3707, 2000.
10. Fisher DA, Smith JF, Pillar JS, St. Denis SH, and Cheng JB. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 246: 570-577, 1998.
11. Fuhrmann M, Jahn HU, Seybold J, Neurohr C, Barnes PJ, Hippenstiel S, Kraemer HJ, and Suttorp N. Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol 20: 292-302, 1999.
12. Gantner F, Gotz C, Gekeler V, Schudt C, Wendel A, and Hatzelmann A. Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation. Br J Pharmacol 123: 1031-1038, 1998.
13. Gardner CN, Robas D, Cawkill D, and Fidock M. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 272: 186-192, 2000.
14. Giembycz MA. Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs 59: 193-212, 2000.
15. Giembycz MA. Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 10: 1361-1379, 2001.
16. Giembycz MA, Corrigan CJ, Seybold J, Newton R, and Barnes PJ. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 118: 1945-1958, 1996.
17. Glavas NA, Ostenson C, Schaefer JB, Vasta V, and Beavo JA. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci USA 98: 6319-6324, 2001.
18. Han P, Zhu X, and Michaeli T. Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272: 16152-16157, 1997.
19. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, and Thompson RA. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 122: 97-103, 1989.
20. Hetman JM, Soderling SH, Glavas NA, and Beavo JA. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc Natl Acad Sci USA 97: 472-476, 2000.
21. Hirst SJ, Barnes PJ, and Twort CH. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am J Respir Cell Mol Biol 7: 574-581, 1992.
22. Houslay MD. PDE4 cAMP-specific phosphodiesterases. Prog Nucleic Acid Res Mol Biol 69: 249-315, 2001.
23. Jeffery PK. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Found Syrup 234: 149-161, 2001.
24. Lee R, Wolda S, Moon E, Esselstyn J, Hertel C, and Lerner A. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP. Cell Signal 14: 277-284, 2002.
25. Li L, Yee C, and Beavo JA. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283: 848-851, 1999.
26. Loughney K, Snyder PB, Uher L, Rosman GJ, Ferguson K, and Florio VA. Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase. Gene 234: 109-117, 1999.
27. Maier JA, Hla T, and Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 265: 10805-10808, 1990.
28. Martinez A, Castro A, Gil C, Miralpeix M, Segarra V, Domenech T, Beleta J, Palacios JM, Ryder H, Miro X, Bonet C, Casacuberta JM, Azorin F, Pina B, and Puigdomenech P. Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors. J Med Chem 43: 683-689, 2000.
29. Michaeli T, Bloom TJ, Martins T, Loughney K, Ferguson K, Riggs M, Rodgers L, Beavo JA, and Wigler M. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J Biol Chem 268: 12925-12932, 1993.
30. Miro X, Casacuberta JM, Gutierrez-Lopez MD, de Landazuri MO, and Puigdomenech P. Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-alpha. Biochem Biophys Res Commun 274: 415-421, 2000.
31. Nemoz G, Zhang R, Sette C, and Conti M. Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells. FEBS Lett 384: 97-102, 1996.
32. Peachell PT, Weston MC, and Drummer J. Characterisation of phosphodiesterases in human lung mast cells and basophils (Abstract). Br J Pharmacol 134: 67P, 2001.
33. Renauld JC. New insights into the role of cytokines in asthma. J Clin Pathol 54: 577-589, 2001.
34. Sasaki T, Kotera J, and Omori K. Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Biochem J 361: 211-220, 2002.
35. Sasaki T, Kotera J, Yuasa K, and Omori K. Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 271: 575-583, 2000.
36. Seamons R, Hinzpeter A, MacKenzie C, MacKenzie S, Houslay M, and van Heeke G. Expression profile of Phophodiesterases 4, 3 and 7 in resting and activated epithelial cells (Abstract). Br J Pharmacol 135: 2002.
37. Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, and Zauli G. Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication. Proc Natl Acad Sci USA 97: 14620-14625, 2000.
38. Seybold J, Newton R, Wright L, Finney PA, Suttorp N, Barnes PJ, Adcock IM, and Giembycz MA. Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization. J Biol Chem 273: 20575-20588, 1998.
39. Tenor H, Staniciu L, Schudt C, Hatzelmann A, Wendel A, Djukanovic R, Church MK, and Shute JK. Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes. Clin Exp Allergy 25: 616-624, 1995.
40. Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel anti-asthma agents. Am J Respir Crit Care Med 157: 351-370, 1998.
41. Torphy TJ, Barnette MS, Underwood DC, Griswold DE, Christensen SB, Murdoch RD, Nieman RB, and Compton CH. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulm Pharmacol Ther 12: 131-135, 1999.
42. Wang PP, Wu R, Egan W, and Billah MM. Cloning, characterization, and tissue distribution of mouse phosphodiesterase 7A1. Biochem Biophys Res Commun 276: 1271-1277, 2000.
43. Wort SJ, Woods M, Warner TD, Evans TW, and Mitchell JA. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 25: 104-110, 2001.
44. Wright LC, Seybold J, Robichaud A, Adcock IM, and Barnes PJ. Phosphodiesterase expression in human epithelial ells. Am J Physiol Lung Cell Mol Physiol 275: L694-L700, 1998.